Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
US10981977B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 17, 2020 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Jun 17, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or is therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.